Skip to content

Aztreonam

DRUG17 trials

Sponsors

Micurx Pharmaceuticals Inc., Pfizer Inc., Uppsala Universitet, Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire De Nimes

Conditions

Bacterial InfectionBlood Stream InfectionCRE ColonizationCarbapenem-resistant EnterobacteralesComplicated Skin and Soft Tissue InfectionCystic FibrosisDiabetic Foot InfectionsGonorrhea

Phase 1

Phase 2

Phase 3

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
CompletedNCT01499277
PfizerComplicated Skin and Soft Tissue Infection
Start: 2012-05-31End: 2015-01-31Updated: 2017-09-06
Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
CompletedNCT01811732
Melinta Therapeutics, Inc.Skin and Subcutaneous Tissue Bacterial Infections
Start: 2013-04-30End: 2014-07-31Updated: 2017-09-27
Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
CompletedNCT01984684
Melinta Therapeutics, Inc.Skin and Subcutaneous Tissue Bacterial Infections, Skin Structures and Soft Tissue Infections
Start: 2014-05-31End: 2016-01-31Updated: 2017-11-17
Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.
TerminatedNCT02202135
PfizerComplicated Skin and Soft Tissue Infection
Start: 2014-06-30End: 2015-01-31Updated: 2017-09-06
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
CompletedNCT02276482
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Skin Diseases, Bacterial, Skin Diseases, Infectious
Start: 2015-03-25End: 2018-09-17Updated: 2019-08-07
A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections
RecruitingCTIS2022-500257-16-00
Micurx Pharmaceuticals Inc.Diabetic Foot Infections
Start: 2023-03-17Target: 791Updated: 2025-07-15
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit. Multicentric non-inferiority randomised controlled trial
CompletedCTIS2023-505108-52-00
Assistance Publique Hopitaux De ParisIntensive Care, Ventilator-associated Pneumonia
Start: 2023-12-20End: 2025-09-19Target: 628Updated: 2025-04-23
Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation
Not yet recruitingNCT07759453
IRCCS Azienda Ospedaliero-Universitaria di BolognaCarbapenem-resistant Enterobacterales, CRE Colonization, Liver Transplant
Start: 2026-10-01End: 2029-09-30Target: 168Updated: 2026-08-12
FOSFOLD - Fosfomycin trometamol compared with another active antibiotic relay therapy for the treatment of acute Escherichia coli pyelonephritis in elderly women: a randomized, multicenter, non-inferiority trial
Not yet recruitingCTIS2025-521663-13-00
Assistance Publique Hopitaux De ParisWomen aged 75 years or older presenting with E. coli pyelonephritis
Target: 312Updated: 2026-08-21

Phase 4

Related Papers

Open Forum Infectious Diseases2018-09-1031 citations